Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Samrat Pharmachem

Sector: Healthcare | Industry: Drugs & Pharma
R 89.20 0.15  | 0.17% 5.13% 8.19 27.56
BSE Price: Oct 22, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 2019 89.20 0.15 0.17% 85.10 89.05 531 85.10 - 90.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,161 P/B: 1.26 NSE Code:
52-Week Range: R 47.50 - 106.45 Dividend Yield: 0.00% BSE Code: 530125
TTM EPS: R 10.89 Book Value: R 71.00 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Samrat Pharmachem 65.19 4.21 24.49 5.13 30.35 29.47 22.51
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 19.58 20.70 10.91
Net Profit -52.26 72.09 44.73
EPS -52.26 72.09 44.73
Book Value 8.29 13.41 8.84
Average
Operating Margin 3.27 5.07 4.11
Net Margin 1.38 2.41 1.67
Return on Networth 7.96 13.01 8.73
Return on Investment 11.80 17.08 12.60
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -2.60 43.63 -2.60
Operating Profit 31.65 481.44 31.65
Net Profit 43.74 4,352.38 43.74
EPS 43.73 4,353.13 43.73
TTM
Revenue 9.69 25.67 9.69
Operating Profit 64.27 11.05 64.27
Net Profit 119.01 26.32 119.01
EPS 119.01 26.32 119.01
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Samrat Pharmachem 27.56 121.96 3.36 2.75 7.96 1.26 8.19
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
News & Announcements
Contact Information

Company: Samrat Pharmachem Ltd.

Address: Plot No A2 / 3445, G I D C Phase 4, Opp. P C I, Ankleshwar, Gujarat - 393002 | Phone: 02646- 220774 | Fax: 02646- 251291

Email: [email protected]

Website: www.samratpharmachem.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
5.30
Piotroski F-Score
7
Modified C-Score
3
5-Years Price to Earnings
8.19
5-Years Price to Book
1.26
Earnings Yield
EBIT / Enterprise value
17.42%
PEG
Price / Earnings to growth ratio
0.25
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59